๐Ÿ—‚๏ธ Navigation

Verge Genomics

We use human data and AI to develop better drugs faster.

Visit Website โ†’

Overview

Verge Genomics is a clinical-stage biotechnology company that has developed an all-in-human, AI-powered drug discovery platform called CONVERGEยฎ. The platform uses machine learning to analyze one of the world's largest proprietary multi-omics databases from human tissue to map the complex causes of diseases like ALS and Parkinson's. These insights are then used to develop proprietary drug candidates.

โœจ Key Features

  • CONVERGEยฎ platform
  • All-in-human data approach
  • Multi-omics database from human tissue
  • Machine learning for target identification
  • Focus on neurodegenerative diseases

๐ŸŽฏ Key Differentiators

  • Exclusive focus on neurodegenerative diseases.
  • Proprietary all-in-human multi-omics database.
  • Vertically integrated platform from data to clinic.

Unique Value: Accelerates the discovery of drugs for neurodegenerative diseases by using an AI platform that analyzes proprietary human genomic data.

๐ŸŽฏ Use Cases (3)

Drug discovery for neurodegenerative diseases (ALS, Parkinson's) Target identification from human data Translational medicine

โœ… Best For

  • Has advanced a drug candidate for ALS, discovered through their platform, into clinical trials.

๐Ÿ’ก Check With Vendor

Verify these considerations match your specific requirements:

  • NA

๐Ÿ† Alternatives

Recursion Pharmaceuticals BenevolentAI

Reduces the reliance on animal models by using an all-in-human approach, potentially leading to a higher probability of clinical success.

๐Ÿ’ป Platforms

NA

๐Ÿ”Œ Integrations

NA

๐Ÿ›Ÿ Support Options

  • โœ“ Email Support
  • โœ“ Dedicated Support (NA tier)

๐Ÿ’ฐ Pricing

Contact for pricing

Free tier: NA

Visit Verge Genomics Website โ†’